Início
Mercados
Gráficos e ideias
Algo
Notícias
Market
Corretoras
Baixar
Calendário econômico
Sinais de Negociação
Terminal web
Heatmap
Pressione
/
para pesquisar: @user, $symbol, ...
Pesquisar
Login
Criar uma conta
Português
English
Русский
中文
Español
日本語
Deutsch
한국어
Français
Italiano
Türkçe
CMMB
#4814
Chemomab Therapeutics Ltd. American Depositary Share
1.690
0
USD
-0.59%
Setor:
Cuidados de saúde
Base:
USD
Moeda do lucro:
USD
Faixa diária
Faixa anual
Mudança diária
-0.59%
Mudança mensal
-12.89%
Mudança em 6 meses
+14.58%
Mudança anual
+14.58%
Fechamento anterior
1.700
0
Abrir
1.690
0
Bid
Ask
Mínimo
1.690
0
High
1.690
0
Volume
2
Mercados
Ações
Cuidados de saúde
CMMB
Abrir gráfico completo
Financials
Visão geral
Relatórios
Estatísticas
Trimestral
Ano
Valor
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
115.94 K
712.78 K
690.61 K
887.8 K
1.18 M
7.19 M
—
Valuation ratios
Enterprise value
—
—
-5.4 M
-7.38 M
2.46 M
4.3 M
-21.16 M
Price to earnings ratio
—
—
24.3
5.22
46.41
91.67
153.83
Price to sales ratio
—
—
—
—
—
—
—
Price to cash flow ratio
—
—
-32.85
-5.35
-42.24
-75.64
-138.3
Price to book ratio
—
—
18.47
7.44
48.01
68.26
125.95
Enterprise value to EBITDA ratio
—
—
—
—
—
—
—
Profitability ratios
Return on assets %
-1.88
-0.19
-0.64
-1.09
-0.82
-0.65
0.67
Return on equity %
-3.25
-0.2
-0.76
-1.43
-1.03
-0.73
0.78
Return on invested capital %
-2 982.15
-207.03
-312.09
-715.06
-7 606.39
-19.9 K
—
Gross margin %
100
—
—
—
—
—
—
Operating margin %
-7 977.24
—
—
—
—
—
—
EBITDA margin %
-7 922.07
—
—
—
—
—
—
Net margin %
-8 006.21
—
—
—
—
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
2.37
23.66
6.18
4.32
4.98
9.08
23.21
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0.01
—
—
—
—
—
—
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
—
-0.36
-0.4
-0.17
-0.02
0.01
EBIT per share
—
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
—
Cash per share
—
—
0.24
0.16
0.16
0.02
0.71
Net current asset value per share
—
—
0.73
0.36
0.18
0.03
1.17
Tangible book value per share
—
—
0.64
0.29
0.15
0.02
0.97
Working capital per share
—
—
0.61
0.27
0.14
0.02
0.92
Book value per share
—
—
0.64
0.29
0.15
0.02
0.97
Notícias
Chemomab’s nebokitug shows disease-modifying potential in PSC trial
Chemomab reports positive 48-week data for PSC drug nebokitug
ALKS to Enter Sleep Disorder Market With $2.1B Avadel Acquisition
Best Momentum Stocks to Buy for Oct. 23
New Strong Buy Stocks for Oct. 23: MQ, GES and More
SNY's Efdoralprin Alfa Meets Key Endpoints in Rare Disease Study
Roche's Gazyva Secures FDA Nod for Label Expansion in Lupus Nephritis
NVO's Rybelsus Gets FDA Nod to Reduce Heart Risk in Diabetes Patients
ESPR Aims to Diversify With Rare Liver Disease Candidate, Stock Up
NVO and LLY Stocks Slide as Trump Signals Price Cuts for GLP-1 Drugs
Viatris Acquires Aculys Pharma to Expand Neurology Portfolio in Japan
CORT Files MAA for Relacorilant in Platinum-Resistant Ovarian Cancer